Sara Gusella

Most-cited papers

1. ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors

   L. Evangelista, A. Bianchi, A. Annovazzi, R. Sciuto +46 more

   2023Cancers14 citations Open access

   Semantic Scholar

   Save

2. Amiodarone-Induced Thyrotoxicosis: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR)

   S. Censi, V. Bodanza, J. Manso, Sara Gusella +6 more

   2018Clinical Nuclear Medicine14 citations Open access

   Semantic Scholar

   Save

3. Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs)

   M. Balma, R. Laudicella, E. Gallio, Sara Gusella +9 more

   2023Life11 citations Open access

   Semantic Scholar

   Save

4. Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study

   M. De Rimini, Andrea Bianchi, A. Annovazzi, D. D'Arienzo +21 more

   2024Clinical and translational imaging2 citations Open access

   Semantic Scholar

   Save

5. Turning Fluids into Data for Precision Oncology: A Multidisciplinary Tumor Board Approach to Malignant Pleural Effusions

   Domenico Damiani, I. Girolami, E. Hanspeter, C. Mian +10 more

   2026Biomedicines1 citations

   Semantic Scholar

   Save

6. Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs)

   M. Balma, Riccardo Laudicella, E. Gallio, Sara Gusella +9 more

   1 citations

   Semantic Scholar

   Save

7. Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study

   A. Bianchi, M. De Rimini, R. Sciuto, A. Annovazzi +46 more

   2023Cancer Biotherapy and Radiopharmaceuticals0 citations

   Semantic Scholar

   Save